ASCI move in to clamp misleading COVID-19 claims in India Ranjan Narula and Daleep Kumar of RNA, Technology and IP Attorneys explain how the Advertising Standards Council of India is acting to prevent misleading claims about coronavirus cures and remedies. By Daleep Kumar & Ranjan Narula January 25 2021
Australian government rediscovers R&D value amid COVID-19 crisis By Karen Sinclair & Sarah Cox December 18 2020
How can domain name owners protect themselves from scammers? By Managing IP Correspondent December 17 2020
Breaking the class ceiling: what one lawyer’s story tells us about D&I By Rachel Wilkinson-Duffy December 15 2020
More trademark and design strategies for a post-Brexit world By Beverley Potts & Jens Matthes December 15 2020
Unpleasant surprises: combatting bad-faith filings in third countries By Gregor Versondert December 15 2020
Drug patent expiry in 2021: Opportunities and challenges in the Korean market By Min Son January 12 2021
Restricting the scope of claims by introducing disclaimers in Taiwan By Chiu-Ling Lin January 12 2021
German court rules against automated dispensing of medicinal products By Christian Meyer January 07 2021
China set to introduce further protection for AI-related innovations By Xiaoming Zhang January 07 2021
Preparations for amending Thailand’s Patent Act gather pace By Darani Vachanavuttivong December 09 2020
Employing a trademark as a domain name is not genuine use By Irem Girenes Yucesoy & Mutlu Yildirim Köse December 09 2020
